NDC 0378-2046 – Tacrolimus
Tacrolimus 1 mg/1 · Capsule · Oral
Product NDC0378-2046
Product details
- Brand name
- Tacrolimus
- Generic name
- Tacrolimus
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA090596
- Marketed since
- September 17, 2010
- Listing expires
- December 31, 2026
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Active ingredients
- Tacrolimus 1 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0378-2046-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2046-01) | Sep 17, 2010 |
Recalls mentioning this NDC
- D-1057-2020 Apr 1, 2020 · Class III
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles. - D-066-2013 Dec 5, 2012 · Class II
Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
Other Tacrolimus products
- 50090-5581 Tacrolimus 1 mg/1 · Capsule · A-S Medication Solutions
- 50090-5596 Tacrolimus 1 mg/1 · Capsule · A-S Medication Solutions
- 16729-042 Tacrolimus 1 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-041 Tacrolimus .5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-422 Tacrolimus 1 mg/g · Ointment · Accord Healthcare Inc.
- 16729-421 Tacrolimus .3 mg/g · Ointment · Accord Healthcare Inc.
- 16729-043 Tacrolimus 5 mg/1 · Capsule · Accord Healthcare Inc.
- 82983-402 Tacrolimus 5 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 82983-400 Tacrolimus .5 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 82983-401 Tacrolimus 1 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 68084-450 Tacrolimus 1 mg/1 · Capsule · American Health Packaging
- 68084-449 Tacrolimus .5 mg/1 · Capsule · American Health Packaging